AI Drug Discovery for Pharma and Biotech

Drug discovery

415

papers

On emerging therapies

Overview

Treacher Collins syndrome (TCS) is a rare autosomal dominant craniofacial disorder caused by mutations in TCOF1 (81-93% of cases), POLR1C, or POLR1D. It features bilateral hypoplasia of zygomatic bones, mandible, and ear anomalies, often with conductive hearing loss, cleft palate, and eyelid colobomas. Airway compromise, feeding difficulties, and psychosocial challenges are common, though intelligence is typically unaffected [1][6][12].

Population

  • Occurs in 1:50,000 live births; 60% from de novo mutations, 40% familial [1][4][6].

Burden

  • Chronic respiratory/feeding issues (28-33% cleft palate), hearing loss (50-96%), and psychosocial impacts (low self-esteem, depression). Requires lifelong multidisciplinary care with ≥5 surgeries in severe cases [5][7][17].

Therapies

  • Surgical: Airway stabilization (tracheostomy/mandibular distraction), cleft palate repair, craniofacial reconstruction (ages 5-7), and ear surgery (>6 years) [1][8][11].

  • Supportive: Hearing aids, speech therapy, orthodontics, and psychological services [3][8][13].

Categories: rare bone diseases, rare developmental anomalies during embryogenesis, rare genetic diseases, rare ophthalmic disorders, rare otorhinolaryngological diseases, rare surgical maxillo-facial diseases

Research Papers

415 drug discovery papers about Treacher-Collins syndrome. Recent publications:

415 drug discovery papers about Treacher-Collins syndrome. Recent publications:

categories:

Small molecules

cell therapies
2025-08-06 | Reconstruction of Zygoma in Total Agenesis in Treacher-Collins Syndrome Using Kerfed Rib Grafts - A Retrospective Study.

Reconstruction of zygomatic agenesis in Treacher-Collins syndrome (TCS) poses a significant challenge. Traditional bone grafting techniques often fail to address the complex three-dimensional (3D) anatomy and biomechanical demands. This study introduces an approach using kerfed rib grafts and titanium scaffolding for such reconstructions. A retrospective review was conducted on six TCS patients (five males, one female; mean age 20.17 ± 2.91 years) with zygomatic agenesis. Pre-operative 3D computed tomography imaging guided surgical planning. Kerfed rib grafts, harvested via a subperiosteal approach, were meticulously contoured and secured to the maxilla and zygomatic root using pre-contoured titanium plates through bicoronal and intraoral incisions. Lateral canthal ligaments were repositioned and hypoplastic maxillae augmented with recombinant human bone morphogenetic protein-2 (rhBMP2). All six patients underwent successful single-stage reconstruction without intraoperative or post-operative complications, including infection or donor-site morbidity. Over a 12-month follow-up, stable reconstructions with significant improvements in facial symmetry and function were observed. Radiographic assessments confirmed adequate integration of rib grafts and maintained structural stability; no revision surgeries were required. Kerfed rib grafts, combined with titanium scaffolding, offer superior conformability, reduced donor-site morbidity and improved aesthetic outcomes compared to traditional techniques for severe zygomatic hypoplasia in TCS. This approach addresses the limitations of calvarial and non-kerfed rib grafts by providing enhanced flexibility, stress distribution and vascularisation. Long-term studies are needed to evaluate the durability of these reconstructions.

Open article ↗



2025-04-02 | Mandibular Lengthening by Distraction for Airway Obstruction in Treacher-Collins Syndrome: The 30-Year Results.

Treacher-Collins syndrome is a rare facial clefting disorder, the management of which remains among the most challenging for craniofacial teams. Herein, we report the long-term outcome of early mandibular lengthening by distraction osteogenesis for established airway obstruction in Treacher-Collins syndrome. This case, which was the first literature report in this clinical scenario1, has subsequently been reviewed at skeletal maturity2 and can now be addressed more than 30 years later.

Open article ↗



2024-09-03 | DISTRACTION OSTEOGENESIS IN SEVERE UPPER AIRWAY OBSTRUCTION DUE TO MANDIBULAR MICROGNATHIA

Introduction: Distraction Osteogenesis (DO) is a good solution solving respiratory distress when other proceduresare failed in severe micrognathia. it is an alternative treatment correcting mandibular hypoplasia. In this study, distraction with a dynamic osteosynthesis system (MD-DOS) for gradual lengthen the mandible with severe hypoplasia. Latency period was seven days. Distraction was performed three times daily for 14 days with rate 0.33 mm. Retention was nine weeks. The mandible had been elongated improving the air way and relive of obstruction.Aim of the study: Evaluation of airway improvement following mandibular distraction osteogenesis in pediatric population with mandibular micrognathia with severe upper airway obstruction. Materials and Methods: Twenty patients aged from 5 month and 5 years (mean age is 3.86 years) with micrognathia and sever airway obstruction had been treated with mandibular distraction osteogenesis (MDO). All patients had been evaluated by a multidisciplinary team. Indications for surgery included frequent apneic episodes with severe desaturation (70%). The study treats patients with congenital anomalies as congenital ankylosis, Pierre Robin sequence (PRS), Hemifacial microsomia, Treacher Collins syndrome and Goldenhar syndrome. Detection of airway obstruction correction were done by comparing pre-operative and post-operative sleep lab study (polysomnography).Results: Cephalometric radiograph, OPG and CT get data for planning the mandibular osteotomy and distractor application for mandibular lengthening and restoring the airway with accepted variable complications on 20 patients age from 5 months to 5 years.Conclusions: Mandibular distraction osteogenesis is a valuable treatment for severe airway obstruction due to mandibular hypoplasia when other procedures are failed .

Open article ↗



2023-11-08 | Cochlear implantation for severe mixed hearing loss caused by Treacher Collins syndrome: Case report

Introduction. Treacher Collins syndrome (TCS) is a rare genetic condition characterized by typical head and neck malformations occurring in 1:50,000 newborns. Permanent conductive or mixed hearing loss of various degrees is diagnosed in 50% of individuals with TCS. A prerequisite for speech and language development in children with permanent mixed hearing impairment is the application of one of the bone conduction hearing aids. Choosing an adequate hearing aid in this case depends primarily on the degree of hearing impairment and the type of ear malformation. Case report. We present a female patient with multiple genetic malformations due to TCS. The patient was, immediately after birth, referred for audiological evaluation because of considerable ear and face malformations. Using a hearing test battery, permanent mixed, predominantly conductive, bilateral hearing loss of severe degree was diagnosed. The use of bone conduction hearing aids (including the Vibrant? Soundbridge middle ear implant) in the patient did not give the expected results ? sufficient amplification for adequate speech and language development. Only after cochlear implantation at the age of nine did the patient?s hearing threshold stabilize and her communication and academic potential develop to full capacity. Conclusion. If a middle ear implant is not sufficient for adequate amplification, cochlear implantation should be considered as an appropriate solution for treating severe permanent mixed hearing impairment in patients with TCS.

Open article ↗



2023-05-03 | Use of adipose derived stem cells in Treacher Collins syndrome.

Treacher Collins syndrome (TCS) is a rare congenital disorder of craniofacial development. TCS occurs with an incidence of 1:50,000, and more than 60% of TCS cases have no previous family history and arise as the result of de novo mutations. The high rate of de novo mutations, together with the extreme variability in the degree to which individuals can be affected, makes the provision of genetic counseling extremely complicated. Consequently, every case of TCS is unique and needs to be assessed individually. Patients with TCS frequently undergo multiple reconstructive surgeries from birth through adulthood, which rarely are fully corrective in the long-term. The nascent field of regenerative medicine offers the promise to improve some of these treatments. In particular, structural fat grafting (SFG) seems to be a good strategy not only to restore the normal volume and contour of the face, but also to provide a source of adipose-derived stem cells (ADSCs) with a multilineage differentiation potential. In this work, we present genetical analyses of ADSC affected by TCS. ADSCs from were analyzed for their stemness properties and shared many characteristics with those of a healthy subject. Screening of the genome of the TCS patient using array-Comparative Genomic Hybridization allowed us to identify some chromosomal imbalances that are probably associated with TCS. We found that some alterations, involving the TIMELESS gene, were usually associated with embryonic stem cells. With the aim to improve the final results, we need to consider combining knowledge of genetic alterations and expression profiles as a fundamental step before starting with surgical procedures.

Open article ↗



small molecules
2026-06-19 | Ossification of the mandible: A regional composite model of intramembranous, parachondral, and endochondral mechanisms.

To catalogue the ossification mechanisms operating along the proximal-distal axis of the human mandible and integrate them into a unified regional framework. Narrative review of embryological, molecular, transcriptomic, and clinical genetics evidence identified through structured searches of PubMed, Scopus, and Web of Science. The type of evidence (human, animal, in vitro, or combined) underpinning each major finding was tracked. Five non-overlapping mechanisms operate across ten mandibular regions: (i) intramembranous ossification of the body, ramus, and coronoid process; (ii) parachondral ossification, defined as intramembranous bone formation in mesenchyme adjacent to Meckel's cartilage (MC) under MC-derived paracrine guidance (BMP5, BMP7, FGF7, SEMA3A from the intermediate MC) and used as the operative descriptor for mandibular body formation; (iii) endochondral ossification of primary cartilage at the symphysis and anterior MC midsegment, via chondrocyte-to-osteoblast transdifferentiation; (iv) endochondral ossification of secondary cartilage at the condylar and angular processes, with viable hypertrophic chondrocytes and chondroid bone; and (v) perichondral ossification at the MC surface. Transdifferentiation executes mechanism (iii) and is not a separate mode. Posterior MC degradation proceeds via autophagy, apoptosis, and chondroclastic resorption, with independent chondral centres near dental primordia contributing further. Treacher Collins syndrome, cleidocranial dysplasia, and Pierre Robin sequence reflect disruptions at different mechanistic levels. The mandible is a composite structure employing multiple ossification modes in a region-specific manner; parachondral ossification most accurately characterises mandibular body formation. The framework carries translational implications for tissue engineering, distraction osteogenesis, and prenatal molecular rescue, evidenced only preclinically in a Treacher Collins mouse model.

Open article ↗



2026-04-27 | N-acetylcysteine as a potential therapeutic agent for Treacher Collins syndrome: evidence from craniofacial defect suppression in polr1d crispant zebrafish

Treacher Collins syndrome (TCS; OMIM: 154,500) is a rare autosomal dominant craniofacial disorder. POLR1D mutations account for ~ 5% of familial TCS, yet the mechanism underlying POLR1D-mediated cranial neural crest cell (CNCC) dysfunction and targeted therapies for TCS remain elusive. Oxidative stress-induced CNCC loss is a key driver of TCS-related craniofacial malformations, suggesting antioxidants may hold therapeutic potential. We employed polr1d crispant zebrafish, which faithfully recapitulate the core phenotypic features of TCS, to evaluate the therapeutic potential of N-acetylcysteine (NAC), a clinically approved antioxidant agent. Zebrafish embryos were treated with 0.5 mM to 1.0 mM NAC from 6 to 72 h post-fertilization (hpf). PHH3 immunofluorescence staining was performed at 24 hpf to detect the proliferation of CNCCs. TUNEL staining was used to assess CNCC apoptosis at 48 hpf, and Alcian Blue staining was applied at 72 hpf to analyze craniofacial cartilage morphology. Additionally, qRT-PCR was conducted to quantify the expression levels of P53-pathway genes for exploring the underlying mechanism of NAC intervention. NAC treatment reduced CNCC apoptosis by 42% in polr1d crispant zebrafish, with a statistically significant difference relative to untreated controls (p = 0.006). This was accompanied by marked recovery of craniofacial cartilages (Meckel’s, palatoquadrate, ceratohyal), with their length/width parameters approaching wild-type levels (p < 0.001). Notably, mRNA levels of p53 showed no significant differences, suggesting that the p53-mediated apoptotic pathway may not be transcriptionally activated. NAC mitigates CNCCs loss and ameliorates TCS-like craniofacial defects in polr1d crispant zebrafish, independently of transcriptional activation of the p53 pathway. Our findings highlight oxidative stress as a tractable target for POLR1D-related TCS and provide preclinical evidence for antioxidant use in embryonic TCS prevention. Future studies will optimize NAC dosing in mammalian models to advance clinical translation.

Open article ↗



2026-01-01 | P323: Non-surgical management of an infant with Treacher Collins syndrome using the orthodontic airway plate: A case report with one-year follow-up

Beyond the panel: Expanding the differential diagnosis of congenital

Open article ↗



2025-07-01 | Maternal antioxidant treatment partially rescues developmental defects in a Drosophila Polr1D mutant model.

Drosophila melanogaster is a versatile in vivo platform for small-molecule screening across many disease models. Here, we utilized a Drosophila model carrying a clinically relevant mutation in Polr1D to test the antioxidant N-acetyl- L -cysteine (NAC) for therapeutic potential. Treating heterozygous Polr1D mothers with NAC partially suppressed the developmental defects of their homozygous Polr1D mutant larvae. These findings are consistent with antioxidant rescue effects observed in zebrafish and mouse models of Treacher Collins Syndrome (TCS). Our results demonstrate the value of a Polr1D mutant Drosophila model for identifying chemical suppressors and accelerating the discovery of promising therapeutics in disorders like TCS.

Open article ↗



2025-05-03 | Tissue-specific requirement of Polr1D in the prothoracic gland for ecdysone-mediated developmental transitions in Drosophila melanogaster.

POLR1D is a shared subunit of RNA Polymerases I and III, which transcribe the rRNA incorporated into ribosomes. Mutations in POLR1D cause Treacher Collins syndrome, a craniofacial disorder that arises from impaired ribosome biogenesis in neural crest cells. Previously, we found that RNAi knockdown of Polr1D in several non-neural Drosophila tissues caused developmental defects that phenocopy mutations affecting ecdysone signaling. Ecdysone is a steroid hormone produced in the prothoracic gland (PG) of insects that triggers developmental transitions. Here, we show that Polr1D is required for PG development and ecdysone production to facilitate larval developmental transitions. We found that Polr1D RNAi in the PG causes larval developmental arrest due to defective peripheral ecdysone signaling. We also found that Polr1D is required for the growth of PG cells and for maintaining nucleolar structure. We found that Polr1D is required for the synthesis of mature ribosomes and the production of the Pol III-transcribed 7SK RNA. Furthermore, developmental arrest of Polr1D RNAi larvae and Polr1D mutant (G30R) larvae was partially rescued by treatment with exogenous ecdysone. These results demonstrate a role for Drosophila Polr1D in PG development and suggest that disruptions in human Polr1D might impact additional cell types during development.

Open article ↗



gene therapies
2026-04-02 | Prenatal Ultrasound and Genetic Diagnosis of EFTUD2 Haploinsufficiency in Two Fetuses: A Case Series.

Mandibulofacial dysostosis with microcephaly (MFDM) is caused by haploinsufficiency of EFTUD2 gene. This syndrome is characterized by microcephaly, malar and mandibular hypoplasia, ear abnormalities, developmental delay, and intellectual disability. In this study, we report two cases of fetuses presenting a phenotype consistent with MFDM and confirmed EFTUD2 gene variants. The patients were referred following abnormal ultrasound findings. Genetic diagnostics in both cases revealed heterozygous variants in the EFTUD2 gene that had not been previously reported prenatally. In the first patient, exome sequencing identified a c.2698_2701del p.(Val865Serfs*34), while in the second a novel large deletion involving multiple genes, including the entire EFTUD2 gene, was detected by microarray analysis. Prenatal diagnosis of MFDM requires precise ultrasound assessment. Therefore, consideration of characteristic features observed in fetuses with MFDM is essential for differential diagnosis and guiding targeted genetic testing.

Open article ↗



2026-02-25 | A Novel Association Between Mandibulofacial Dysostosis with Microcephaly and Congenital Diaphragmatic Hernia.

Mandibulofacial dysostosis with microcephaly (MFDM) is a rare craniofacial syndrome due to pathogenic variants in EFTUD2. Affected patients may present with cleft palate, dysmorphic craniofacial features, short stature, microcephaly, developmental delay/intellectual disability, and variable congenital anomalies. Gastrointestinal anomalies include esophageal atresia and tracheoesophageal fistula. Congenital diaphragmatic hernia (CDH) has not been previously reported. Here, we present a novel case of MFDM with CDH in a late preterm female with multiple congenital malformations observed prenatally. Postnatal genetic testing was diagnostic for a heterozygous de novo pathogenic variant in EFTUD2, consistent with a diagnosis of MFDM.

Open article ↗



2025-12-28 | A novel pathogenic variant in POLR1D (c.220dup, p.His74ProfsTer8) causes Treacher Collins syndrome type 2 in a Chinese patient: a case report.

Treacher Collins syndrome type 2 (TCS2; OMIM# 613717) is a rare genetic disorder of craniofacial development caused by pathogenic variants in the POLR1D gene. The characteristic clinical features include downward-slanting palpebral fissures, micrognathia, hypoplastic zygomatic arches, lower eyelid coloboma, and malformations of the external and middle ears. In this study, we report a 2-year-and-3-month-old male of Miao ethnicity with TCS2 caused by a novel heterozygous pathogenic POLR1D variant (NM_015972.4: c.220dup, p.His74ProfsTer8), inherited from his unaffected father. He presented with downward slanting of bilateral palpebral fissures, low-set ears, and microretrognathia, along with middle ear deformities, both confirmed by CT with 3D reconstruction, accompanied by conductive hearing loss. During the neonatal period, he exhibited severe neonatal airway compromise due to combined tongue-based obstruction and laryngomalacia, necessitating a tracheostomy. Based on the above clinical manifestations and genotype, he met the diagnosis of TCS2. The tracheostomy tube was successfully decannulated at approximately 10 months of age. His prognosis was good. This study expands the mutational spectrum of POLR1D-related TCS2 and underscores the vital role of multidisciplinary airway intervention in severe presentations. As an exceptionally rare disorder, this case provides crucial genotype-phenotype correlations that advance both clinical management strategies and molecular understanding of TCS2 pathogenesis.

Open article ↗



2025-10-30 | Imaging of Congenital and Developmental Conditions of the Temporomandibular Joint.

This article covers congenital and developmental conditions of the temporomandibular joint (TMJ), including Pierre Robin sequence, Treacher Collins syndrome, oculoauriculovertebral spectrum, and various forms of condylar dysplasia such as condylar hypoplasia and hyperplasia. Hemimandibular elongation, hemimandibular hyperplasia, and coronoid hyperplasia are also discussed. Emphasis is placed on the imaging characteristics that aid in diagnosis and management, highlighting the critical role of advanced imaging in evaluating TMJ abnormalities, guiding treatment planning, and monitoring growth and development in affected individuals.

Open article ↗



2025-09-27 | RNA Polymerase I Dysfunction Underlying Craniofacial Syndromes: Integrated Genetic Analysis Reveals Parallels to 22q11.2 Deletion Syndrome.

POLR1A and related gene variants cause craniofacial and developmental syndromes, including Acrofacial Dysostosis-Cincinnati, Treacher-Collins types 2-4, and TWIST1-associated disorders. Using a patient case integrated with molecular analyses, we aimed to clarify shared pathogenic mechanisms and propose these conditions as part of a spectrum of RNA polymerase I (Pol I)-related ribosomopathies. A patient with a heterozygous POLR1A variant underwent clinical evaluation. Findings were integrated with a literature review of craniofacial syndromes to identify overlapping fea tures. Protein-protein and gene-gene interactions were analyzed with STRING and Pathway Commons, a structural modeling of POLR1A assessed the mutation's impact. The patient exhibited features overlapping with Sweeney-Cox, Saethre-Cox, Robinow-Sorauf, and Treacher-Collins types 2-4, supporting a shared spectrum. Computational analyses identified POLR1A-associated partners and pathways converging on Pol I function, ribosomal biogenesis, and nucleolar processes. Structural modeling of the Met496Ile variant suggested disruption of DNA binding and polymerase activity, linking molecular dysfunction to the clinical phenotype. Significant clinical and genetic overlap exists among Saethre-Chotzen, Sweeney-Cox, Treacher-Collins types 2-4, and Acrofacial Dysostosis-Cincinnati. POLR1A and related Pol I subunits provide a mechanistic basis through impaired nucleolar organization and rRNA transcription, contributing to abnormal craniofacial development. Integrative protein, gene, and structural analyses support classifying these syndromes as Pol I-related ribosomopathies, with implications for diagnosis, counseling, and future mechanistic or therapeutic studies.

Open article ↗



cell therapies
2025-08-06 | Reconstruction of Zygoma in Total Agenesis in Treacher-Collins Syndrome Using Kerfed Rib Grafts - A Retrospective Study.

Reconstruction of zygomatic agenesis in Treacher-Collins syndrome (TCS) poses a significant challenge. Traditional bone grafting techniques often fail to address the complex three-dimensional (3D) anatomy and biomechanical demands. This study introduces an approach using kerfed rib grafts and titanium scaffolding for such reconstructions. A retrospective review was conducted on six TCS patients (five males, one female; mean age 20.17 ± 2.91 years) with zygomatic agenesis. Pre-operative 3D computed tomography imaging guided surgical planning. Kerfed rib grafts, harvested via a subperiosteal approach, were meticulously contoured and secured to the maxilla and zygomatic root using pre-contoured titanium plates through bicoronal and intraoral incisions. Lateral canthal ligaments were repositioned and hypoplastic maxillae augmented with recombinant human bone morphogenetic protein-2 (rhBMP2). All six patients underwent successful single-stage reconstruction without intraoperative or post-operative complications, including infection or donor-site morbidity. Over a 12-month follow-up, stable reconstructions with significant improvements in facial symmetry and function were observed. Radiographic assessments confirmed adequate integration of rib grafts and maintained structural stability; no revision surgeries were required. Kerfed rib grafts, combined with titanium scaffolding, offer superior conformability, reduced donor-site morbidity and improved aesthetic outcomes compared to traditional techniques for severe zygomatic hypoplasia in TCS. This approach addresses the limitations of calvarial and non-kerfed rib grafts by providing enhanced flexibility, stress distribution and vascularisation. Long-term studies are needed to evaluate the durability of these reconstructions.

Open article ↗



2025-04-02 | Mandibular Lengthening by Distraction for Airway Obstruction in Treacher-Collins Syndrome: The 30-Year Results.

Treacher-Collins syndrome is a rare facial clefting disorder, the management of which remains among the most challenging for craniofacial teams. Herein, we report the long-term outcome of early mandibular lengthening by distraction osteogenesis for established airway obstruction in Treacher-Collins syndrome. This case, which was the first literature report in this clinical scenario1, has subsequently been reviewed at skeletal maturity2 and can now be addressed more than 30 years later.

Open article ↗



2024-09-03 | DISTRACTION OSTEOGENESIS IN SEVERE UPPER AIRWAY OBSTRUCTION DUE TO MANDIBULAR MICROGNATHIA

Introduction: Distraction Osteogenesis (DO) is a good solution solving respiratory distress when other proceduresare failed in severe micrognathia. it is an alternative treatment correcting mandibular hypoplasia. In this study, distraction with a dynamic osteosynthesis system (MD-DOS) for gradual lengthen the mandible with severe hypoplasia. Latency period was seven days. Distraction was performed three times daily for 14 days with rate 0.33 mm. Retention was nine weeks. The mandible had been elongated improving the air way and relive of obstruction.Aim of the study: Evaluation of airway improvement following mandibular distraction osteogenesis in pediatric population with mandibular micrognathia with severe upper airway obstruction. Materials and Methods: Twenty patients aged from 5 month and 5 years (mean age is 3.86 years) with micrognathia and sever airway obstruction had been treated with mandibular distraction osteogenesis (MDO). All patients had been evaluated by a multidisciplinary team. Indications for surgery included frequent apneic episodes with severe desaturation (70%). The study treats patients with congenital anomalies as congenital ankylosis, Pierre Robin sequence (PRS), Hemifacial microsomia, Treacher Collins syndrome and Goldenhar syndrome. Detection of airway obstruction correction were done by comparing pre-operative and post-operative sleep lab study (polysomnography).Results: Cephalometric radiograph, OPG and CT get data for planning the mandibular osteotomy and distractor application for mandibular lengthening and restoring the airway with accepted variable complications on 20 patients age from 5 months to 5 years.Conclusions: Mandibular distraction osteogenesis is a valuable treatment for severe airway obstruction due to mandibular hypoplasia when other procedures are failed .

Open article ↗



2023-11-08 | Cochlear implantation for severe mixed hearing loss caused by Treacher Collins syndrome: Case report

Introduction. Treacher Collins syndrome (TCS) is a rare genetic condition characterized by typical head and neck malformations occurring in 1:50,000 newborns. Permanent conductive or mixed hearing loss of various degrees is diagnosed in 50% of individuals with TCS. A prerequisite for speech and language development in children with permanent mixed hearing impairment is the application of one of the bone conduction hearing aids. Choosing an adequate hearing aid in this case depends primarily on the degree of hearing impairment and the type of ear malformation. Case report. We present a female patient with multiple genetic malformations due to TCS. The patient was, immediately after birth, referred for audiological evaluation because of considerable ear and face malformations. Using a hearing test battery, permanent mixed, predominantly conductive, bilateral hearing loss of severe degree was diagnosed. The use of bone conduction hearing aids (including the Vibrant? Soundbridge middle ear implant) in the patient did not give the expected results ? sufficient amplification for adequate speech and language development. Only after cochlear implantation at the age of nine did the patient?s hearing threshold stabilize and her communication and academic potential develop to full capacity. Conclusion. If a middle ear implant is not sufficient for adequate amplification, cochlear implantation should be considered as an appropriate solution for treating severe permanent mixed hearing impairment in patients with TCS.

Open article ↗



2023-05-03 | Use of adipose derived stem cells in Treacher Collins syndrome.

Treacher Collins syndrome (TCS) is a rare congenital disorder of craniofacial development. TCS occurs with an incidence of 1:50,000, and more than 60% of TCS cases have no previous family history and arise as the result of de novo mutations. The high rate of de novo mutations, together with the extreme variability in the degree to which individuals can be affected, makes the provision of genetic counseling extremely complicated. Consequently, every case of TCS is unique and needs to be assessed individually. Patients with TCS frequently undergo multiple reconstructive surgeries from birth through adulthood, which rarely are fully corrective in the long-term. The nascent field of regenerative medicine offers the promise to improve some of these treatments. In particular, structural fat grafting (SFG) seems to be a good strategy not only to restore the normal volume and contour of the face, but also to provide a source of adipose-derived stem cells (ADSCs) with a multilineage differentiation potential. In this work, we present genetical analyses of ADSC affected by TCS. ADSCs from were analyzed for their stemness properties and shared many characteristics with those of a healthy subject. Screening of the genome of the TCS patient using array-Comparative Genomic Hybridization allowed us to identify some chromosomal imbalances that are probably associated with TCS. We found that some alterations, involving the TIMELESS gene, were usually associated with embryonic stem cells. With the aim to improve the final results, we need to consider combining knowledge of genetic alterations and expression profiles as a fundamental step before starting with surgical procedures.

Open article ↗



small molecules
2026-06-19 | Ossification of the mandible: A regional composite model of intramembranous, parachondral, and endochondral mechanisms.

To catalogue the ossification mechanisms operating along the proximal-distal axis of the human mandible and integrate them into a unified regional framework. Narrative review of embryological, molecular, transcriptomic, and clinical genetics evidence identified through structured searches of PubMed, Scopus, and Web of Science. The type of evidence (human, animal, in vitro, or combined) underpinning each major finding was tracked. Five non-overlapping mechanisms operate across ten mandibular regions: (i) intramembranous ossification of the body, ramus, and coronoid process; (ii) parachondral ossification, defined as intramembranous bone formation in mesenchyme adjacent to Meckel's cartilage (MC) under MC-derived paracrine guidance (BMP5, BMP7, FGF7, SEMA3A from the intermediate MC) and used as the operative descriptor for mandibular body formation; (iii) endochondral ossification of primary cartilage at the symphysis and anterior MC midsegment, via chondrocyte-to-osteoblast transdifferentiation; (iv) endochondral ossification of secondary cartilage at the condylar and angular processes, with viable hypertrophic chondrocytes and chondroid bone; and (v) perichondral ossification at the MC surface. Transdifferentiation executes mechanism (iii) and is not a separate mode. Posterior MC degradation proceeds via autophagy, apoptosis, and chondroclastic resorption, with independent chondral centres near dental primordia contributing further. Treacher Collins syndrome, cleidocranial dysplasia, and Pierre Robin sequence reflect disruptions at different mechanistic levels. The mandible is a composite structure employing multiple ossification modes in a region-specific manner; parachondral ossification most accurately characterises mandibular body formation. The framework carries translational implications for tissue engineering, distraction osteogenesis, and prenatal molecular rescue, evidenced only preclinically in a Treacher Collins mouse model.

Open article ↗



2026-04-27 | N-acetylcysteine as a potential therapeutic agent for Treacher Collins syndrome: evidence from craniofacial defect suppression in polr1d crispant zebrafish

Treacher Collins syndrome (TCS; OMIM: 154,500) is a rare autosomal dominant craniofacial disorder. POLR1D mutations account for ~ 5% of familial TCS, yet the mechanism underlying POLR1D-mediated cranial neural crest cell (CNCC) dysfunction and targeted therapies for TCS remain elusive. Oxidative stress-induced CNCC loss is a key driver of TCS-related craniofacial malformations, suggesting antioxidants may hold therapeutic potential. We employed polr1d crispant zebrafish, which faithfully recapitulate the core phenotypic features of TCS, to evaluate the therapeutic potential of N-acetylcysteine (NAC), a clinically approved antioxidant agent. Zebrafish embryos were treated with 0.5 mM to 1.0 mM NAC from 6 to 72 h post-fertilization (hpf). PHH3 immunofluorescence staining was performed at 24 hpf to detect the proliferation of CNCCs. TUNEL staining was used to assess CNCC apoptosis at 48 hpf, and Alcian Blue staining was applied at 72 hpf to analyze craniofacial cartilage morphology. Additionally, qRT-PCR was conducted to quantify the expression levels of P53-pathway genes for exploring the underlying mechanism of NAC intervention. NAC treatment reduced CNCC apoptosis by 42% in polr1d crispant zebrafish, with a statistically significant difference relative to untreated controls (p = 0.006). This was accompanied by marked recovery of craniofacial cartilages (Meckel’s, palatoquadrate, ceratohyal), with their length/width parameters approaching wild-type levels (p < 0.001). Notably, mRNA levels of p53 showed no significant differences, suggesting that the p53-mediated apoptotic pathway may not be transcriptionally activated. NAC mitigates CNCCs loss and ameliorates TCS-like craniofacial defects in polr1d crispant zebrafish, independently of transcriptional activation of the p53 pathway. Our findings highlight oxidative stress as a tractable target for POLR1D-related TCS and provide preclinical evidence for antioxidant use in embryonic TCS prevention. Future studies will optimize NAC dosing in mammalian models to advance clinical translation.

Open article ↗



2026-01-01 | P323: Non-surgical management of an infant with Treacher Collins syndrome using the orthodontic airway plate: A case report with one-year follow-up

Beyond the panel: Expanding the differential diagnosis of congenital

Open article ↗



2025-07-01 | Maternal antioxidant treatment partially rescues developmental defects in a Drosophila Polr1D mutant model.

Drosophila melanogaster is a versatile in vivo platform for small-molecule screening across many disease models. Here, we utilized a Drosophila model carrying a clinically relevant mutation in Polr1D to test the antioxidant N-acetyl- L -cysteine (NAC) for therapeutic potential. Treating heterozygous Polr1D mothers with NAC partially suppressed the developmental defects of their homozygous Polr1D mutant larvae. These findings are consistent with antioxidant rescue effects observed in zebrafish and mouse models of Treacher Collins Syndrome (TCS). Our results demonstrate the value of a Polr1D mutant Drosophila model for identifying chemical suppressors and accelerating the discovery of promising therapeutics in disorders like TCS.

Open article ↗



2025-05-03 | Tissue-specific requirement of Polr1D in the prothoracic gland for ecdysone-mediated developmental transitions in Drosophila melanogaster.

POLR1D is a shared subunit of RNA Polymerases I and III, which transcribe the rRNA incorporated into ribosomes. Mutations in POLR1D cause Treacher Collins syndrome, a craniofacial disorder that arises from impaired ribosome biogenesis in neural crest cells. Previously, we found that RNAi knockdown of Polr1D in several non-neural Drosophila tissues caused developmental defects that phenocopy mutations affecting ecdysone signaling. Ecdysone is a steroid hormone produced in the prothoracic gland (PG) of insects that triggers developmental transitions. Here, we show that Polr1D is required for PG development and ecdysone production to facilitate larval developmental transitions. We found that Polr1D RNAi in the PG causes larval developmental arrest due to defective peripheral ecdysone signaling. We also found that Polr1D is required for the growth of PG cells and for maintaining nucleolar structure. We found that Polr1D is required for the synthesis of mature ribosomes and the production of the Pol III-transcribed 7SK RNA. Furthermore, developmental arrest of Polr1D RNAi larvae and Polr1D mutant (G30R) larvae was partially rescued by treatment with exogenous ecdysone. These results demonstrate a role for Drosophila Polr1D in PG development and suggest that disruptions in human Polr1D might impact additional cell types during development.

Open article ↗



gene therapies
2026-04-02 | Prenatal Ultrasound and Genetic Diagnosis of EFTUD2 Haploinsufficiency in Two Fetuses: A Case Series.

Mandibulofacial dysostosis with microcephaly (MFDM) is caused by haploinsufficiency of EFTUD2 gene. This syndrome is characterized by microcephaly, malar and mandibular hypoplasia, ear abnormalities, developmental delay, and intellectual disability. In this study, we report two cases of fetuses presenting a phenotype consistent with MFDM and confirmed EFTUD2 gene variants. The patients were referred following abnormal ultrasound findings. Genetic diagnostics in both cases revealed heterozygous variants in the EFTUD2 gene that had not been previously reported prenatally. In the first patient, exome sequencing identified a c.2698_2701del p.(Val865Serfs*34), while in the second a novel large deletion involving multiple genes, including the entire EFTUD2 gene, was detected by microarray analysis. Prenatal diagnosis of MFDM requires precise ultrasound assessment. Therefore, consideration of characteristic features observed in fetuses with MFDM is essential for differential diagnosis and guiding targeted genetic testing.

Open article ↗



2026-02-25 | A Novel Association Between Mandibulofacial Dysostosis with Microcephaly and Congenital Diaphragmatic Hernia.

Mandibulofacial dysostosis with microcephaly (MFDM) is a rare craniofacial syndrome due to pathogenic variants in EFTUD2. Affected patients may present with cleft palate, dysmorphic craniofacial features, short stature, microcephaly, developmental delay/intellectual disability, and variable congenital anomalies. Gastrointestinal anomalies include esophageal atresia and tracheoesophageal fistula. Congenital diaphragmatic hernia (CDH) has not been previously reported. Here, we present a novel case of MFDM with CDH in a late preterm female with multiple congenital malformations observed prenatally. Postnatal genetic testing was diagnostic for a heterozygous de novo pathogenic variant in EFTUD2, consistent with a diagnosis of MFDM.

Open article ↗



2025-12-28 | A novel pathogenic variant in POLR1D (c.220dup, p.His74ProfsTer8) causes Treacher Collins syndrome type 2 in a Chinese patient: a case report.

Treacher Collins syndrome type 2 (TCS2; OMIM# 613717) is a rare genetic disorder of craniofacial development caused by pathogenic variants in the POLR1D gene. The characteristic clinical features include downward-slanting palpebral fissures, micrognathia, hypoplastic zygomatic arches, lower eyelid coloboma, and malformations of the external and middle ears. In this study, we report a 2-year-and-3-month-old male of Miao ethnicity with TCS2 caused by a novel heterozygous pathogenic POLR1D variant (NM_015972.4: c.220dup, p.His74ProfsTer8), inherited from his unaffected father. He presented with downward slanting of bilateral palpebral fissures, low-set ears, and microretrognathia, along with middle ear deformities, both confirmed by CT with 3D reconstruction, accompanied by conductive hearing loss. During the neonatal period, he exhibited severe neonatal airway compromise due to combined tongue-based obstruction and laryngomalacia, necessitating a tracheostomy. Based on the above clinical manifestations and genotype, he met the diagnosis of TCS2. The tracheostomy tube was successfully decannulated at approximately 10 months of age. His prognosis was good. This study expands the mutational spectrum of POLR1D-related TCS2 and underscores the vital role of multidisciplinary airway intervention in severe presentations. As an exceptionally rare disorder, this case provides crucial genotype-phenotype correlations that advance both clinical management strategies and molecular understanding of TCS2 pathogenesis.

Open article ↗



2025-10-30 | Imaging of Congenital and Developmental Conditions of the Temporomandibular Joint.

This article covers congenital and developmental conditions of the temporomandibular joint (TMJ), including Pierre Robin sequence, Treacher Collins syndrome, oculoauriculovertebral spectrum, and various forms of condylar dysplasia such as condylar hypoplasia and hyperplasia. Hemimandibular elongation, hemimandibular hyperplasia, and coronoid hyperplasia are also discussed. Emphasis is placed on the imaging characteristics that aid in diagnosis and management, highlighting the critical role of advanced imaging in evaluating TMJ abnormalities, guiding treatment planning, and monitoring growth and development in affected individuals.

Open article ↗



2025-09-27 | RNA Polymerase I Dysfunction Underlying Craniofacial Syndromes: Integrated Genetic Analysis Reveals Parallels to 22q11.2 Deletion Syndrome.

POLR1A and related gene variants cause craniofacial and developmental syndromes, including Acrofacial Dysostosis-Cincinnati, Treacher-Collins types 2-4, and TWIST1-associated disorders. Using a patient case integrated with molecular analyses, we aimed to clarify shared pathogenic mechanisms and propose these conditions as part of a spectrum of RNA polymerase I (Pol I)-related ribosomopathies. A patient with a heterozygous POLR1A variant underwent clinical evaluation. Findings were integrated with a literature review of craniofacial syndromes to identify overlapping fea tures. Protein-protein and gene-gene interactions were analyzed with STRING and Pathway Commons, a structural modeling of POLR1A assessed the mutation's impact. The patient exhibited features overlapping with Sweeney-Cox, Saethre-Cox, Robinow-Sorauf, and Treacher-Collins types 2-4, supporting a shared spectrum. Computational analyses identified POLR1A-associated partners and pathways converging on Pol I function, ribosomal biogenesis, and nucleolar processes. Structural modeling of the Met496Ile variant suggested disruption of DNA binding and polymerase activity, linking molecular dysfunction to the clinical phenotype. Significant clinical and genetic overlap exists among Saethre-Chotzen, Sweeney-Cox, Treacher-Collins types 2-4, and Acrofacial Dysostosis-Cincinnati. POLR1A and related Pol I subunits provide a mechanistic basis through impaired nucleolar organization and rRNA transcription, contributing to abnormal craniofacial development. Integrative protein, gene, and structural analyses support classifying these syndromes as Pol I-related ribosomopathies, with implications for diagnosis, counseling, and future mechanistic or therapeutic studies.

Open article ↗



Access all drug discovery papers and probability of success in trials forecasts:

Access all drug discovery papers and probability of success in trials forecasts:

Drug Discovery Landscape

0 orphan drug designations.

0 orphan drug designations.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.

Explority AI logo

228 Park Ave S,
New York, USA.

At Explority, we build first-of-its-kind AI to bring clarity to the earliest and riskiest stages of pharmaceutical research by forecasting which therapies are most likely to succeed. Explority AI web and mobile applications are properties of the Explority AI Inc., a company registered in the United States (File No. 10320493).
For all questions: support@explority.ai

Copyright © 2026 Explority AI Inc.